Patients shocked as insulin prices climb higher
Injectable insulin, which keeps some diabetics alive and keeps others out of serious health crises, has soared in price in the last few years.
Jan 29, 2016
1
13
Injectable insulin, which keeps some diabetics alive and keeps others out of serious health crises, has soared in price in the last few years.
Jan 29, 2016
1
13
The Justice Department is probing some drug pricing practices of pharmaceutical giants Merck and Eli Lilly, the companies disclosed Friday in securities filings.
Nov 6, 2015
0
10
A less-expensive version of the world's top-selling insulin, Sanofi's Lantus, could go on sale in the U.S. late next year.
Sep 28, 2015
0
3
Jardiance sharply reduced chances of dying in diabetic patients at high risk of heart complications, a study shows, making the Type 2 diabetes medication the first shown to lengthen diabetics' lives.
Sep 17, 2015
0
12
Eli Lilly received some European legal backing for its top product, the lung cancer treatment Alimta, on Thursday when a British court upheld a patent protecting a vitamin regimen administered with the drug.
Jun 25, 2015
0
8
It started out as a treatment for arthritis. But steered by science, it could become a first new approach in two decades for treating the damage that diabetes inflicts on the kidneys of millions of people.
Jun 10, 2015
0
52
Swiss-based pharmaceutical company Novartis reported a large jump in first-quarter net profit Thursday as it recorded one-time gains from deals with other drug companies.
Apr 23, 2015
0
7
The Food and Drug Administration is warning doctors against over-prescribing testosterone-boosting drugs for men, saying the popular treatments have not been established as safe or effective for common age-related issues ...
Mar 3, 2015
0
7
Novartis AG is closing its manufacturing plant in Puerto Rico as part of a major overhaul of its business, the company said in a statement Friday.
Jan 16, 2015
0
9
(HealthDay)—U.S. Food and Drug Administration approval of the anti-cancer drug Cyramza (ramucirumab) has been expanded to include aggressive non-small-cell lung cancer (NSCLC), the agency said Friday.
Dec 14, 2014
0
0